Cellular Goods launches UK’s first CBG face serum
CBG has anti-inflammatory and antioxidant properties.
CBG has anti-inflammatory and antioxidant properties.
A public consultation has now been launched on the science innovation and research centre that will be established by Peel NRE.
Pharma titan Pfizer is to acquire Arena Pharmaceuticals which has a pipeline in cannabinoid therapeutics.Â
2021 has been a good year for the cannabis industry, says the new Brightfield Group report.
The global cannabinoid pharmaceuticals market has been projected to reach £1.53bn (€1.8bn).
American cannabinoid manufacturer and supplier is expanding to supply the European market.
Piauhy Labs will study the efficacy of cannabinoids for the treatment of diseases such as autism, epilepsy and Alzheimer’s.
Broughton will be focusing on accelerating products to market within strategic markets including the cannabinoids industry.Â
Oxford Cannabinoid Technologies has signed agreements to accelerate the development of a pain management solution using phytocannabinoids.
Oxford Cannabinoid Technologies has signed a worldwide exclusive licence agreement with Canopy Growth Corporation.
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.